CGRP Education & Research Forum
Already a member? Become a member Register
youtubeLinkedIn
News

Slides

These slide decks bring together extensive clinical trial data supporting the efficacy and safety of the CGRP monoclonal antibodies, erenumab, fremanezumab, galcanezumab and eptinezumab, and the CGRP receptor antagonists (gepants), ubrogepant, rimegepant and atogepant.

AtogepantAtogepantErenumabErenumabEptinezumabEptinezumabGalcanezumabGalcanezumabFremanezumabFremanezumabRimegepantRimegepantUbrogepantUbrogepant
Take a look at the background slides here >